Facebook
X
LinkedIn
Forward
Beyond "GLP-1s": Mechanistic Insights into Amylin and Glucagon Pathways in Next Generation Obesity Medicines (NUTRITION 2026 On Demand Collection)
This course is included in the NUTRITION 2026 On Demand Collection.
Semaglutide and tirzepatide have transformed obesity treatment, but casually grouping the newest generation of highly effective medicines under the umbrella term "GLP 1s" overlooks the rapidly expanding landscape of metabolic targets in obesity medicine. As emerging therapies harness mechanisms involving amylin and glucagon signaling, understanding these pathways is increasingly essential. This session features internationally recognized experts Dr. Christelle Le Foll (amylin biology) and Dr. Kirk Habegger (glucagon biology) who will discuss the molecular mechanisms of these systems and their roles in appetite regulation, weight loss, and the management of obesity related complications.
Originally presented at NUTRITION 2026, ASN's flagship meeting which was held July 25-28 in National Harbor, MD
Speakers
Christelle Le Foll, PhD
Group Leader, Institute of Veterinary Physiology
University of Zurich
Kirk Habegger, PhD
Professor, Department of Medicine, Division of Endocrinology, Diabetes & Metabolism
The University of Alabama at Birmingham
Drew Sayer, PhD
Assistant Professor, Department of Family and Community Medicine
The University of Alabama at Birmingham
Course summary
- 1.50 Attendance
Learners are eligible to download a Certificate of Attendance upon activity completion. A Certificate of Attendance confirms the learner has completed the activity and does not confer any continuing education credit to the learner from ASN.
This activity includes the following presentations:
Welcome and Introductions
Drew Sayer, PhD
The University of Alabama at Birmingham
Unexpected Metabolic Actions of Glucagon Receptor Agonism in Incretin-Based Therapies
Kirk Habegger, PhD
The University of Alabama at Birmingham
Neuropharmacology and Metabolic Actions of Amylin: Linking Brain Circuits to Obesity Treatment
Christelle Le Foll, PhD
University of Zurich
Panel Discussion / Questions and Answers
Continuing education credit is not available for this activity. A Certificate of Attendance can be downloaded by learners who complete the course.
Available Credit
- 1.50 Attendance
Learners are eligible to download a Certificate of Attendance upon activity completion. A Certificate of Attendance confirms the learner has completed the activity and does not confer any continuing education credit to the learner from ASN.